What is he best known for?
The fields of study he is best known for:
- Cancer
- Immune system
- Gene
His primary areas of investigation include Immunology, Interleukin 12, Cancer research, Cell culture and Genetic enhancement.
In his study, which falls under the umbrella issue of Immunology, Sarcoma is strongly linked to Systemic administration.
His study in Interleukin 12 is interdisciplinary in nature, drawing from both Spleen, CD8, Cytokine and Immunotherapy.
Hideaki Tahara has researched Cancer research in several fields, including Virus, Interleukin 18 and Toxicity.
His Cell culture study combines topics in areas such as Immune system and Cytotoxicity.
His work on Genetic enhancement is being expanded to include thematically relevant topics such as Viral vector.
His most cited work include:
- Recombinant IL-12 administration induces tumor regression in association with IFN-gamma production. (745 citations)
- Expression of E-cadherin cell adhesion molecules in human breast cancer tissues and its relationship to metastasis (588 citations)
- Phase I evaluation of intravenous recombinant human interleukin 12 in patients with advanced malignancies. (459 citations)
What are the main themes of his work throughout his whole career to date?
Hideaki Tahara mainly investigates Cancer research, Immunology, Interleukin 12, Genetic enhancement and Immune system.
Hideaki Tahara interconnects Cancer, CD8, Transfection, Lymphatic system and Antibody in the investigation of issues within Cancer research.
His work deals with themes such as Cytotoxic T cell and In vivo, which intersect with Immunology.
In his research on the topic of Interleukin 12, Interferon is strongly related with Interleukin.
The Genetic enhancement study combines topics in areas such as Cytokine, Virology, Molecular biology, Viral vector and Electroporation.
As a part of the same scientific study, Hideaki Tahara usually deals with the Immune system, concentrating on Antigen and frequently concerns with Cancer immunotherapy.
He most often published in these fields:
- Cancer research (41.28%)
- Immunology (36.63%)
- Interleukin 12 (26.74%)
What were the highlights of his more recent work (between 2010-2021)?
- Cancer research (41.28%)
- Immunology (36.63%)
- Internal medicine (14.53%)
In recent papers he was focusing on the following fields of study:
The scientist’s investigation covers issues in Cancer research, Immunology, Internal medicine, Immune system and Antibody.
Hideaki Tahara has included themes like Cancer cell, Apoptosis, CD8, Lymphatic system and Metastasis in his Cancer research study.
Hideaki Tahara integrates Immunology and Advertising in his research.
His studies in Internal medicine integrate themes in fields like Diabetes mellitus, Diabetic mouse, Systemic administration and Oncology.
Hideaki Tahara interconnects Cellular immunity, Cellular Immunology, In vivo and Mechanism of action in the investigation of issues within Antibody.
His work deals with themes such as Interleukin 12, FOXP3, Bone marrow and Genetically modified organism, which intersect with Cancer immunotherapy.
Between 2010 and 2021, his most popular works were:
- Defining the critical hurdles in cancer immunotherapy (132 citations)
- Recommendations from the iSBTc-SITC/FDA/NCI Workshop on Immunotherapy Biomarkers (97 citations)
- Sox9 Is Upstream of MicroRNA-140 in Cartilage (66 citations)
In his most recent research, the most cited papers focused on:
- Cancer
- Immune system
- Gene
Hideaki Tahara mostly deals with Immunology, Immune system, CD8, Antitumor immunity and Cancer.
His Immunology study combines topics from a wide range of disciplines, such as Cancer cell and Molecular targeting.
His Immune system study incorporates themes from Inflammation, Tumor progression, Stromal cell and Metastasis.
His study in CD8 is interdisciplinary in nature, drawing from both Central tolerance, Immune tolerance, Peripheral tolerance, Clonal deletion and Adoptive cell transfer.
The study incorporates disciplines such as Alternative medicine, Translational research and Clinical trial in addition to Cancer.
His Cancer immunotherapy research is multidisciplinary, incorporating elements of Immune checkpoint, Cancer research and IL-2 receptor.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
